From: Opthalmology Times <opthalmologytimes@aci-direct.net>
To: [Opthalmology Times Subscriber]
Subject: Learn from Experts about Netarsudil for the Management of Glaucoma

Click here to view online.

Zogenix
    Click to View Supplement    

 

Aerie Pharmaceuticals convened a group of expert thought leaders in the diagnosis and management of glaucoma to share their insights and experience with Rhopressa® and Rocklatan®. Using case studies of patients in their practices as examples, these thought leaders covered topics such as rationale for treatment, efficacy and safety outcomes, ideal candidates for therapy, and managing patient expectations.

Zogenix

INDICATIONS AND DOSAGE FOR ROCKLATAN® AND RHOPRESSA®

***WAITING FOR WORD DOC COPY*** PLACEHOLDER ONLY

Click here for Full Prescribing
Information for Rocklatan
Click here for Full Prescribing
Information for Rocklatan
Zogenix

Rhopressa and Rocklatan are registered trademarks of Aerie Pharmaceuticals, Inc.
© 2020 Aerie Pharmaceuticals, Inc. All rights reserved.
US-RH0-P-0293

4301 Emperor Blvd., Suite 400 | Durham, NC 27703 | 919-237-5300

This email was sent by: %%Member_Busname%%
%%Member_Addr%%, %%Member_City%%, %%Member_State%%, %%Member_PostalCode%% %%Member_Country%%

Privacy Policy

Update Profile      Manage Subscriptions      Unsubscribe